GlassScriptPhysician profile
David J Cohen
NPI 1306888144
$391,535.21
in general payments reported to CMS, 2019-2025
21 companies · $13K in 2025
The $13K reported for 2025 was more than what 91% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $111K · 2021: $29K · 2022: $82K · 2023: $47K · 2024: $77K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $111K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Food and Beverage: $4,597 · Travel and Lodging: $3,606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $110,676.08 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,221.72 |
| Food and Beverage | $4,596.77 |
| Travel and Lodging | $3,606.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $169,030.87 | 2019-2025 | Mitraclip |
| Edwards Lifesciences Corporation | $141,130.06 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $32,444.75 | 2019-2025 | Sentinel |
| Medtronic Vascular, INC. | $16,556.19 | 2019-2020 | |
| Medtronic, INC. | $16,454.93 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| American Regent | $9,602.18 | 2022 | |
| Zoll Circulation INC | $2,500.00 | 2025 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Jenavalve Technology, INC. | $1,476.08 | 2024-2025 | |
| Teleflex LLC | $1,250.00 | 2022 | |
| Cathworks, INC. | $340.06 | 2023-2024 | Ffrangio |
| Genzyme Corporation | $229.39 | 2024 | |
| Terumo Medical Corporation | $190.97 | 2022 | |
| Philips North America LLC | $92.05 | 2022 | |
| Inari Medical, INC. | $49.66 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Biotronik INC. | $43.03 | 2025 | Nhancer Rx |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $42.28 | 2019 | |
| Heartflow, INC. | $34.03 | 2019 | |
| Sanofi Pasteur INC. | $30.16 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.87 | 2025 | Lifevest |
| Stryker Corporation | $17.65 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.